Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

HomecompanyVildagliptin 274901-16-5 98%
Vildagliptin
Vildagliptin
Vildagliptin

Vildagliptin 274901-16-5 98%

Price Get Latest Price
Packge 1MT1kg5kg10kg25kg
  • Min. Order:10kg
  • Time:2024-01-06

Product Details

  • Product NameVildagliptin
  • CAS No.274901-16-5
  • EINECS No.630-410-0
  • MFC17H25N3O2
  • MW303.4
  • AppearancesolidWhite
  • Melting point 153-155?C
  • storage temp. Keep in dark place,Inert atmosphere,Store in freezer, under -20°C
  • density 1.27
  • Boiling point 531.3±50.0 °C(Predicted)

Company Profile Introduction

Glenmark Pharmaceuticals Limited is a research‐led, global pharmaceutical company, having a presence across branded, generics, and OTC segments; with a focus in the therapy areas of Respiratory, Dermatology and Oncology. The company has four research and development centres, ten world‐class manufacturing facilities spread across five continents, and operations in over eighty countries.

In its quest to be among the first few Indian pharmaceutical companies to develop an innovative drug for the world, Glenmark is treading two parallel paths. One pursues the discovery of a novel chemical or biological entity. The second that leads towards scaling the value chain by creating specialty products, like RYALTRIS®, that address gaps in treatment.

Glenmark Pharmaceuticals and its fully owned US subsidiary Ichnos Sciences together have formed an alliance ‘Ichnos Glenmark Innovation’ to use different modalities, technologies and combined expertise to treat cancer. It has a robust pipeline of innovative molecules, in various stages of clinical development across oncology and immunology.

Glenmark is driven by a continuous commitment to create ‘A New Way for a New World’. Harnessing the potential of our core strengths of innovation, research, and scientific knowledge, we remain determined to consistently challenge established treatment paradigms. It allows us to identify and deliver promising solutions that make a considerable difference to the lives of patients in diverse geographies.

Glenmark Pharmaceuticals Limited

1Y Maharashtra India
  • Since:2020-01-01
  • Address: "Glenmark House, B. D. Sawant Marg, Chakala, Off Western Express Highway, Andheri (E) Mumbai Maharas
INQUIRY